Neurotoxin therapy for inner ear disorders
AssigneeAllergan Sales, Inc.
InventorStephen Donovan
Life of this patent
Estimating the term…
Abstract
Methods for treating otic disorders by local administration of a neurotoxin. A botulinum toxin can be administered to myoclonic middle ear muscles and to inner ear efferent and/or afferent nerves to alleviate otic disorders such as tinnitus, cochlear nerve dysfunction and Meniere's disease.
Claims32
A method for treating an otic disorder, the method comprising the step of local administration of a neurotoxin to an ear, the ear comprising an outer ear, a middle ear and an inner ear.
A method for treating tinnitus, the method comprising the step of local administration of a therapeutic amount of a botulinum toxin to an ear of a human patient, thereby substantially alleviating the tinnitus.
A method for the in vivo treatment of a non-infectious disorder of the middle or inner ear of a human patient, the method comprising the step of local administration to a middle ear or inner ear of a human patient of a therapeutically effective amount of a botulinum toxin, thereby causing an in vivo attenuation of a non-infectious disorder of the middle or inner ear of the human patient.
A method for improving patient function, the method comprising the step of administering a neurotoxin to an ear of a human patient, thereby improving patient function as determined by improvement in one or more of the factors of reduced pain, reduced time spent in bed, improve hearing, increased ambulation, healthier attitude and a more varied lifestyle.
Dependencies are inferred from the claim text.